Pharmacokinetics of Single Dose Intramuscularly Injected Ziprasidone Mesylate in Healthy Volunteers
Yang Qiumin, Yuanda Zhou
Abstract
Yang Qiumin, Yuanda Zhou
Abstract
OBJECTIVE:To study the pharmacokinetics of a single dose of intramuscularly injected ziprasidone mesylate in healthy volunteers.METHODS:A total of10healthy volunteers were received intramuscularly single dose of ziprasidone me-sylate20mg,venous blood samples were taken at different time after intramuscular injection,the concentrations of ziprasidone in serum were determined by HPLC,and the pharmacokinetic parameters were calculated with3p97program.RESULTS:The concentration-time curves of ziprasidone fitted to two-compartment model.The pharmacokinetic parameters were stated as follows,C max was(866.32±482.88)ng/ml;t max was(0.57±0.23)h,t 1/2ke was(2.17±1.04)h,CL was(17.0±9.00)ml/h,AUC 0~12 was(1467.94±644.80)(ng·h)/ml and ACU 0~∝ was(1603.48±722.47)(ng·h)/ml.CONCLUSIONS:The pharmacoki-netics parameters in10healthy volunteers after intramuscular injection of20mg ziprasidone mesylate are in line with that re-ported in the literature.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To study the pharmacokinetics of a single dose of intramuscularly injected ziprasidone mesylate in healthy volunteers.METHODS:A total of10healthy volunteers were received intramuscularly single dose of ziprasidone me-sylate20mg,venous blood samples were taken at different time after intramuscular injection,the concentrations of ziprasidone in serum were determined by HPLC,and the pharmacokinetic parameters were calculated with3p97program.RESULTS:The concentration-time curves of ziprasidone fitted to two-compartment model.The pharmacokinetic parameters were stated as follows,C max was(866.32±482.88)ng/ml;t max was(0.57±0.23)h,t 1/2ke was(2.17±1.04)h,CL was(17.0±9.00)ml/h,AUC 0~12 was(1467.94±644.80)(ng·h)/ml and ACU 0~∝ was(1603.48±722.47)(ng·h)/ml.CONCLUSIONS:The pharmacoki-netics parameters in10healthy volunteers after intramuscular injection of20mg ziprasidone mesylate are in line with that re-ported in the literature.
Key concepts: Ziprasidone, Pharmacokinetics, Pharmacology, Mesylate, Chemistry, Serum concentration, Medicine, Internal medicine